Clinical Trial 37392

Berlin, NJ 08009

Study Summary:

A Randomized, Open-label, Parallel, Phase 2a Study to Determine the Tolerability, Pharmacokinetics, and Efficacy of APD371 in Subjects with Crohn’s disease experiencing Abdominal Pain

Qualified Participants Must:

• Have had Crohn's disease for at least 3 months
• Have chronic moderate to severe abdominal pain

Qualified Participants May Receive:

Transportation options and compensation up to $850 for time and travel may be available.

Clinical trials are medical research studies designed to test the safety and/or effectiveness of new investigational drugs, devices, or treatments in humans. These studies are conducted worldwide for a range of conditions and illnesses. Learn more about clinical research and participating in a study at About Clinical Trials.